Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
03/06/25 • 23 min
1 Listener
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content:
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content:
Previous Episode
Shedding LiGHT on Selective Laser Trabeculoplasty
Interview with Harry A. Quigley, MD, author of Shedding LiGHT on Selective Laser Trabeculoplasty, and guest Michael A. Kass, MD, Washington University School of Medicine in St Louis. Hosted by Neil M. Bressler, MD. Related Content:
Next Episode
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023
Interview with Susan M. Culican, MD, PhD, author of Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023. Hosted by Neil Bressler, MD. Related Content:
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/jama-ophthalmology-author-interviews-8989/continuous-ranibizumab-via-port-delivery-system-vs-monthly-ranibizumab-86833161"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to continuous ranibizumab via port delivery system vs monthly ranibizumab on goodpods" style="width: 225px" /> </a>
Copy